A prospective, multicenter, randomized, double-blind, controlled phase III clinical study on the efficacy and safety of XLF055 combined with metronidazole in the prevention of recurrence of bacterial vaginosis (BV)

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 7f721fc7249f7b98e5c27b921388cce876b0715c
First added on: Apr 23, 2026